Stratasys (SSYS) director Crump details shares, RSUs and option grants

Rhea-AI Filing Summary

STRATASYS LTD. director S. Scott Crump filed an initial ownership report showing a mix of ordinary shares, restricted share units, and stock options. He directly holds 220,155 ordinary shares and an additional 6,113 ordinary shares underlying RSUs that began vesting on November 23, 2025 and will fully vest by November 23, 2026.

Crump also indirectly holds 176,294 ordinary shares through his spouse. His derivative position includes several option grants over ordinary shares, such as 100,000 underlying shares at an exercise price of $19.9600 expiring on April 6, 2027, and additional smaller option blocks expiring between 2031 and 2035. One option grant dated September 30, 2025 vests in 12 equal monthly installments over the same November 23, 2025–November 23, 2026 schedule.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

CRUMP S SCOTT

(Last) (First) (Middle)

C/O STRATASYS, INC., 5995 OPUS PARKWAY

(Street)

MINNETONKA MINNESOTA 55343

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
STRATASYS LTD. [ SSYS ]

3a. Foreign Trading Symbol
[N/A]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares	220,155	D
Ordinary shares	176,294	I	By spouse
Ordinary shares(1)	6,113	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy ordinary shares)	04/06/2018	04/06/2027	Ordinary shares	100,000	$19.96	D
Stock Option (right to buy ordinary shares)	11/23/2022	11/23/2031	Ordinary shares	4,745	$25.03	D
Stock Option (right to buy ordinary shares)	09/15/2023	09/15/2032	Ordinary shares	7,370	$9.5	D
Stock Option (right to buy ordinary shares)	08/08/2024	08/08/2033	Ordinary shares	6,829	$10.25	D
Stock Option (right to buy ordinary shares)	11/07/2025	11/07/2034	Ordinary shares	12,883	$9.32	D
Stock Option (right to buy ordinary shares)	(2)	09/30/2035	Ordinary shares	11,056	$11.45	D

Explanation of Responses:

1. The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") that were granted to the Reporting Person on September 30, 2025 and that vest and settle for underlying ordinary shares in 12 equal monthly installments over a vesting period that commenced on November 23, 2025 and will conclude on the one-year anniversary of the vesting commencement date (November 23, 2026), by which time all such RSUs will be fully vested (and underlying shares issued).

2. The options reported in this row were granted to the Reporting Person by the Issuer on September 30, 2025 and vest and become exercisable in 12 equal monthly installments over a vesting period that commenced on November 23, 2025 and will conclude on the one-year anniversary of the vesting commencement date (November 23, 2026), by which time all such options will be fully vested and exercisable.

	/s/ Vered Ben Jacob, attorney-in-fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Form 3 for STRATASYS (SSYS) show about S. Scott Crump's holdings?

The Form 3 shows that director S. Scott Crump holds ordinary shares directly, additional shares through his spouse, and multiple stock option grants. It also identifies restricted share units that convert into ordinary shares on a defined monthly vesting schedule through November 23, 2026.

How many Stratasys (SSYS) ordinary shares does S. Scott Crump hold directly and indirectly?

S. Scott Crump directly holds 220,155 ordinary shares and indirectly holds 176,294 ordinary shares through his spouse. The filing also lists 6,113 ordinary shares underlying restricted share units that vest monthly, adding to his effective equity exposure as those units settle into shares.

What stock options for Stratasys (SSYS) are reported for S. Scott Crump?

The filing lists several stock option grants over ordinary shares, including 100,000 underlying shares at an exercise price of $19.9600 expiring April 6, 2027. Additional option positions cover smaller underlying share amounts with exercise prices between $9.32 and $25.03, expiring from 2031 through 2035.

How do S. Scott Crump’s Stratasys (SSYS) RSUs vest according to the Form 3?

The RSUs were granted September 30, 2025 and vest in 12 equal monthly installments. The vesting period began November 23, 2025 and will conclude on November 23, 2026, at which point all RSUs will be fully vested and the underlying ordinary shares issued.

What is the vesting schedule for S. Scott Crump’s 2025 Stratasys (SSYS) option grant?

The options granted September 30, 2025 vest and become exercisable in 12 equal monthly installments. Vesting began November 23, 2025 and will finish on November 23, 2026. By that one-year anniversary, all options from this grant will be fully vested and exercisable.

Does the Stratasys (SSYS) Form 3 show any recent insider buying or selling by S. Scott Crump?

The Form 3 functions as an initial ownership statement and only lists holdings, not recent purchases or sales. All transaction entries are classified as holdings, and the transaction summary shows no buy, sell, exercise, gift, or tax-withholding activity reported in this filing.